Search

Your search keyword '"Briedis, V."' showing total 105 results

Search Constraints

Start Over You searched for: Author "Briedis, V." Remove constraint Author: "Briedis, V."
105 results on '"Briedis, V."'

Search Results

1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

2. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

3. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

4. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

5. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

6. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

7. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

8. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

9. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

10. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

11. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

12. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

13. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

16. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

17. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

18. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

19. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

20. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

21. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

22. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

23. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

24. Geolocation with respect to personal privacy for the Allergy Diary app - A MASK study

25. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

27. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

31. Fatty acid composition of sea buckthorn (Hippophae rhamnoides L.) pulp oil of Lithuanian origin stored at different temperatures.

33. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

34. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases: Review

35. In Vitro Study of Cyano-Phycocyanin Release from Hydrogels and Ex Vivo Study of Skin Penetration.

36. Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries.

37. Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022.

38. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.

39. Potential of Naftifine Application for Transungual Delivery.

40. Impact of hospitalization on potentially inappropriate prescribing: a cross-sectional study in an acute geriatric hospital in Lithuania.

41. Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice.

42. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

43. ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.

44. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study.

45. Potential of Chemical and Physical Enhancers for Transungual Delivery of Amorolfine Hydrochloride.

46. Topical antifungal bigels: Formulation, characterization and evaluation.

47. Skin Penetration Enhancement by Natural Oils for Dihydroquercetin Delivery.

48. Testing of resveratrol microemulsion photostability and protective effect against UV induced oxidative stress.

49. Fatty acids penetration into human skin ex vivo: A TOF-SIMS analysis approach.

50. MODELLING AND BIOPHARMACEUTICAL EVALUATION OF CICLOPIROX OLAMINE GELS.

Catalog

Books, media, physical & digital resources